Effectiveness of virtual, group cough modulation therapy for chronic refractory cough [PDF]
ERJ Open ResearchChronic refractory cough is common. A virtual, group-based approach that delivers cough suppression therapy was associated with improvements in cough severity visual analogue scale and Leicester cough questionnaire scores. https://bit.ly/4ltwNul.
Emily C. Kear +8 more
doaj +4 more sources
Nonpharmacological cough control therapy for chronic refractory cough and cough associated with underlying lung disease [PDF]
ERJ Open Research, 2020 Nonpharmacological cough control therapy (CCT) is effective for refractory chronic cough but there is a significant subgroup of nonresponders. CCT appears to be effective in cough associated with underlying disease such as asthma. http://bit.ly/2uCCwu3.
Sana Mohammed +3 more
doaj +5 more sources
Prevalence of refractory and unexplained chronic cough in adults treated in cough centre
ERJ Open ResearchBackground Refractory chronic cough and unexplained chronic cough pose significant clinical challenges, impairing patients’ quality of life. However, a precise definition of refractory chronic cough remains elusive.
Paweł Kukiełka +4 more
doaj +3 more sources
Management of chronic refractory cough in adults. [PDF]
Eur J Intern Med, 2020 Cough is a common respiratory symptom that is considered to be chronic when it lasts more than eight weeks. When severe, chronic cough may significantly impact an individual's quality of life, and such patients are frequently referred for specialist evaluation.
Visca D +4 more
europepmc +5 more sources
Efficacy and safety of P2X3 receptor antagonists in refractory or unexplained chronic cough: an updated systematic review and meta-analysis [PDF]
Frontiers in PharmacologyBackgroundRefractory chronic cough and unexplained chronic cough are increasingly understood as clinical expressions of cough hypersensitivity. P2X3 receptor antagonists have been developed to reduce ATP-mediated airway sensory nerve activation, but ...
Yu-Tong An +6 more
doaj +2 more sources
Prediction of Therapeutic Efficacy of Gabapentin by Hull Airway Reflux Questionnaire in Chronic Refractory Cough [PDF]
Therapeutic Advances in Chronic Disease, 2020 Li Yu, Zhongmin Qiu, Xianghuai Xu
exaly +2 more sources
Multicentre, 2×2 factorial, randomised, open-label trial of neuromodulators and cough control therapy for refractory or unexplained chronic cough: the FORTITUDE trial protocol [PDF]
BMJ OpenIntroduction While clinicians commonly prescribe neuromodulators for the treatment of refractory or unexplained chronic cough, no trials have directly compared these treatments.
Ana Oliveira +21 more
doaj +2 more sources
Clarifying Terminology in Chronic Cough: The Evolving Role of Cough Hypersensitivity Syndrome [PDF]
The Clinical Respiratory JournalChronic cough is defined as a cough lasting no less than 8 weeks, and 10%–42% of patients with chronic cough retain their cough after comprehensive examination and treatment.
Zihang Wang +8 more
doaj +2 more sources
Impaired cough suppression in chronic refractory cough [PDF]
European Respiratory Journal, 2019 Functional brain imaging in individuals with chronic cough demonstrates reduced activation in cortical regions associated with voluntary cough suppression. Little is known about the ability of patients with chronic cough to suppress cough. This study aimed to compare the ability to voluntarily suppress cough during inhaled capsaicin challenge in ...
Peter S.P. Cho +4 more
openaire +4 more sources
BMJ Open Respiratory Research, 2021 Background Cough lasting 3–8 and >8 weeks are defined as subacute/prolonged cough and chronic cough (CC), respectively. Studies have revealed that CC negatively impact patients’ quality of life (QoL).
Yirong Chen +3 more
doaj +1 more source